Komipharm International Co., Ltd. (KOSDAQ: 041960)
South Korea
· Delayed Price · Currency is KRW
3,805.00
-15.00 (-0.39%)
Jan 22, 2025, 1:07 PM KST
Komipharm International Revenue
Komipharm International had revenue of 10.99B KRW in the quarter ending September 30, 2024, with 40.22% growth. This brings the company's revenue in the last twelve months to 54.53B, up 31.47% year-over-year. In the year 2023, Komipharm International had annual revenue of 42.65B with 7.15% growth.
Revenue (ttm)
54.53B
Revenue Growth
+31.47%
P/S Ratio
4.84
Revenue / Employee
345.13M
Employees
158
Market Cap
264.64B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 42.65B | 2.85B | 7.15% |
Dec 31, 2022 | 39.80B | 3.95B | 11.03% |
Dec 31, 2021 | 35.85B | -1.31B | -3.53% |
Dec 31, 2020 | 37.16B | 1.67B | 4.71% |
Dec 31, 2019 | 35.49B | 495.91M | 1.42% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 292.86T |
SK hynix | 57.73T |
LG Energy Solution | 27.17T |
Samsung Biologics Co.,Ltd. | 4,364.39B |
Hyundai Motor Company | 170.28T |
Kia Corporation | 104.63T |
Celltrion | 2,876.25B |
KB Financial Group | 14.11T |